Kidney Function Tests Market Size, Share, Industry, Forecast and outlook (2024-2031)

Kidney Function Tests Market is segmented By Product Type (Dipsticks, Reagents, Disposables, Others), By Test Type (Urine Test, Blood test, Others), By End User (Hospitals, Diagnostic Centers, Research laboratories and institutes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2030

Kidney Function Tests Market Overview

[160 Pages Report] Kidney Function Tests Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 6.2% during the forecast period (2022-2029).

Kidneys are vital organs in the human body. The kidney filters blood, reabsorbs important components and eliminates soluble waste materials from the blood. They require continual regeneration of dead nephrons and proper blood circulation to support cell proliferation. A kidney function test can diagnose renal diseases such as trouble urinating due to excess bodily fluids, swelling in the hands or feet, and a swollen face.

Kidney Function Tests Market - Strategic Insights

For More Insights Download Sample

Kidney Function Tests Market Dynamics

Increasing product launches and FDA approvals for kidney function tests are expected to drive market growth.

In March 2019, the US Food and Drug Administration (FDA) approved the Dip.io urine testing program, developed by Israel-based Healthy.io, which allows patients with chronic illnesses, urinary tract infections, or high-risk pregnant women to check their health using a screening tool. Moreover, Eurofins Viracor acquired Clinical Laboratory Evaluation Program (CLEP) approval in April 2021 for the Viracor TRAC (Transplant Allograft Rejection Check) donor-derived cell-free DNA test and TruGraf blood gene expression assay, which aid in monitoring rejection status in kidney transplant recipients. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High diagnostic process costs, stringent government regulation in protocols for kidney function tests, and the test's incapacity to fully establish the disease are some factors the market is expected to hamper in the forecast period.

Industry Analysis

The kidney function tests market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, reimbursement scenario, pricing analysis etc.

COVID-19 Impact On Kidney Function Tests Market

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 urinary incontinence was widely detected in individuals with numerous infectious and dangerous disorders, according to a study published in medRXiv in Apr2020. Exposure to the urinary tract COVID-19 has been discovered in children aged 0 to 12 who have a little light form of COVID-19. COVID-19 urinary tract infections were discovered from day 1 to day 52 after the disease's onset.

Kidney function markers are used to assess how well the kidneys operate. Some signs are both radioactive and non-radioactive. They show the glomerular filtration rate of the kidneys as well as their concentrating and diluting capabilities (tubular function). Many people would rather purchase a kidney function test over the counter than online. Kidney biopsy is a useful technique.

In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Kidney Function Tests​​​​​​​ Market Segmentation Analysis

Dipsticks segment is expected to hold the largest market share in kidney function tests market

The dipsticks segment is expected to dominate in 2021. The dipstick is a type of plastic stick with a chemical line printed on it in the form of lines; when a dipstick is dipped in urine, the color of the ribbon changes, indicating the presence of aberrant substances such as protein, blood, redness, bacteria, and sugar. This aids in diagnosing various renal and urinary problems, such as chronic kidney disease, bladder infections, and kidney stones. Also, the growing number of people and investment in renal function testing drive some increase.

For instance, Sweden's Elypta AB raised USD 7.0 million in January 2020 for a urine cancer screening test. Therefore, a patient's urine can reveal a lot of information about their health, increasing the use of dipsticks. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Kidney Function Tests​​​​​​​ Market​​​​​​​ Geographical Share

North America region holds the largest market share in the global kidney function tests market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of diabetes, rising incidence of hypertension, rising investments in the development of the healthcare sector, product launches and acquisitions of kidney function tests by market players are some factors the market is expected to boost in the forecast period. For instance, according to the American Diabetes Association, in 2019, 37.3 million Americans, or 11.3% of the population, had diabetes.

​​​​​​​

Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. Moreover, 1.4 million Americans are diagnosed with diabetes every year. In addition, in March 2021, Bio-Techne Corporation published positive preliminary data on its kidney transplant rejection test, ExoTRU (Exosome Transplant Rejection Urine), claiming that it can differentiate between types of kidney rejection, providing critical information to assist clinician decision making, and optimizing patient care. Therefore, it has increased the demand for kidney function tests. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period. 

Kidney Function Tests​​​​​​​ Companies and Competitive Landscape

Major key players in the kidney function tests market are F. Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics, 77 Elektronika Kft, ACON Laboratories, Inc., Beckman Coulter, Abbott, bioMérieux SA, OPTI Medical, Siemens Healthineers.        

Hoffmann-La Roche Ltd:

Overview:

Hoffmann-La Roche Ltd is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. It is one of the largest biotech companies, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and neuroscience. It is a global leader in in-vitro and tissue-based cancer diagnostics and a frontrunner in diabetes management. Its personalized healthcare strategy aims to provide medicines and diagnostics that enable tangible improvements in patients' health, quality of life and survival. Moreover, Roche Molecular, one of four customer-focused areas of Roche Diagnostics Solutions, develops, manufactures and supplies a wide array of innovative molecular diagnostic products, tests, platforms and technologies used to identify and quantify DNA and RNA from different organisms.

­Product Portfolio:

Micral-Test strip: The Micral-Test strip is an easy to use test designed to deliver quick and accurate results, specific for human albumin and sensitive across the diagnostic range.

The global kidney function tests market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.​​​​​​​